
Opinion|Videos|July 22, 2024
Real-World Data for Risdiplam in Adult Patients with Spinal Muscular Atrophy
Panelists examine the available real-world data (RWD) on the use of risdiplam in adult patients with spinal muscular atrophy (SMA) from various studies conducted worldwide, discussing its potential efficacy and safety as a treatment option for adult SMA patients.
Advertisement
Episodes in this series

- Discuss real-world evidence for risdiplam in adult patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Addressing the Unmet Needs of Adults With Spinal Muscular Atrophy
2
Bridging Pediatric and Adult Care in Spinal Muscular Atrophy
3
How P-tau217 Could Shift the Timing of Alzheimer Care
4
Ractigen Completes Phase 2 Enrollment for RAG-17 in SOD1-ALS
5

















